ZOLL® TherOx System

FDA Approves Next-Generation ZOLL TherOx System for Widowmaker Heart Attack Patients

The second-generation ZOLL TherOx System provides SuperSaturated Oxygen (SSO2) Therapy and reduces heart muscle damage in “widowmaker” heart attack patients.
- Advertisement -spot_img

Latest News

ExpressionEdits Raises $13M in Seed Funding to Advance Protein Expression Using AI-Driven Intronization Technology

The funding will accelerate candidate selection for preclinical studies and develop a pipeline of protein-based therapeutics. The primary focus for the pipeline will be recombinant proteins that have historically faced production and manufacturing challenges based on current technology notes ExpressionEdits.
- Advertisement -spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy